Differential effect of amyloid beta on the cytochrome P450 epoxygenase activity in rat brain

Neuroscience

Volumn 194, Issue , 2011, Pages 241-249

  Sarkar, P ^a   Narayanan, J ^a   Harder, D R ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Alzheimer's disease; Amyloid beta; Epoxyeicosatrienoic acids; Epoxygenase

Indexed keywords

11,12 EPOXY 5,8,14 ICOSATRIENOIC ACID; 14,15 EPOXY 5,8,11 ICOSATRIENOIC ACID; AMYLOID BETA PROTEIN; CYTOCHROME P450; CYTOCHROME P450 EPOXYGENASE; EPOXYICOSATRIENOIC ACID; HYDROXYICOSATETRAENOIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN; BRAIN CORTEX; BRAIN MICROSOME; CELL SPECIFICITY; CEREBELLUM; CONTROLLED STUDY; ENZYME ACTIVITY; FATTY ACID SYNTHESIS; HIPPOCAMPUS; MALE; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE SPECIFICITY;

8,11,14-EICOSATRIENOIC ACID; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; ANIMALS, NEWBORN; BRAIN; CYTOCHROME P-450 ENZYME SYSTEM; DISEASE MODELS, ANIMAL; MALE; NEUROPROTECTIVE AGENTS; PRIMARY CELL CULTURE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 80053098381     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.07.058     Document Type: Article

References (65)

1. Abdu E., Bruun D.A., Yang D., Yang J., Inceoglu B., Hammock B.D., Alkayed N.J., Lein P.J. Epoxyeicosatrienoic acids enhance axonal growth in primary sensory and cortical neuronal cell cultures. J Neurochem 2011, 117:632-642.
2. Alkayed N.J., Birks E.K., Hudetz A.G., Roman R.J., Henderson L., Harder D.R. Inhibition of brain P-450 arachidonic acid epoxygenase decreases baseline cerebral blood flow. Am J Physiol 1996, 271:H1541-H1546.
3. Alkayed N.J., Birks E.K., Narayanan J., Petrie K.A., Kohler-Cabot A.E., Harder D.R. Role of P-450 arachidonic acid epoxygenase in the response of cerebral blood flow to glutamate in rats. Stroke 1997, 28:1066-1072.
4. Alkayed N.J., Narayanan J., Gebremedhin D., Medhora M., Roman R.J., Harder D.R. Molecular characterization of an arachidonic acid epoxygenase in rat brain astrocytes. Stroke 1996, 27:971-979.
5. Amruthesh S.C., Falck J.R., Ellis E.F. Brain synthesis and cerebrovascular action of epoxygenase metabolites of arachidonic acid. J Neurochem 1992, 58:503-510.
6. Barclay L.L., Brady P.A. Cerebellar atrophy as a CT marker for mixed dementia. Biol Psychiatry 1992, 31:520-524.
7. Behl C., Davis J.B., Lesley R., Schubert D. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 1994, 77:817-827.
8. Braak H., Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991, 82:239-259.
9. Braak H., Braak E. Evolution of neuronal changes in the course of Alzheimer's disease. J Neural Transm Suppl 1998, 53:127-140.
10. Bruce A.J., Malfroy B., Baudry M. beta-Amyloid toxicity in organotypic hippocampal cultures: protection by EUK-8, a synthetic catalytic free radical scavenger. Proc Natl Acad Sci U S A 1996, 93:2312-2316.
11. Bylund J., Zhang C., Harder D.R. Identification of a novel cytochrome P450, CYP4X1, with unique localization specific to the brain. Biochem Biophys Res Commun 2002, 296:677-684.
12. Chartier-Harlin M.C., Crawford F., Houlden H., Warren A., Hughes D., Fidani L., Goate A., Rossor M., Roques P., Hardy J., et al. Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene. Nature 1991, 353:844-846.
13. Chen J.K., Capdevila J., Harris R.C. Cytochrome p450 epoxygenase metabolism of arachidonic acid inhibits apoptosis. Mol Cell Biol 2001, 21:6322-6331.
14. Dahlgren K.N., Manelli A.M., Stine W.B., Baker L.K., Krafft G.A., LaDu M.J. Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. J Biol Chem 2002, 277:32046-32053.
15. Dhanasekaran A., Al-Saghir R., Lopez B., Zhu D., Gutterman D.D., Jacobs E.R., Medhora M. Protective effects of epoxyeicosatrienoic acids on human endothelial cells from the pulmonary and coronary vasculature. Am J Physiol Heart Circ Physiol 2006, 291:H517-H531.
16. Dietrich H.H., Xiang C., Han B.H., Zipfel G.J., Holtzman D.M. Soluble amyloid-beta, effect on cerebral arteriolar regulation and vascular cells. Mol Neurodegener 2010, 5:15.
17. Dunn K.M., Renic M., Flasch A.K., Harder D.R., Falck J., Roman R.J. Elevated production of 20-HETE in the cerebral vasculature contributes to severity of ischemic stroke and oxidative stress in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 2008, 295:H2455-H2465.
18. Fox N.C., Warrington E.K., Freeborough P.A., Hartikainen P., Kennedy A.M., Stevens J.M., Rossor M.N. Presymptomatic hippocampal atrophy in Alzheimer's disease. A longitudinal MRI study. Brain 1996, 119:2001-2007.
19. Gao S., Hendrie H.C., Hall K.S., Hui S. The relationships between age, sex, and the incidence of Dementia and Alzheimer disease: a meta-analysis. Arch Gen Psychiatry 1998, 55:809-815.
20. Gebremedhin D., Ma Y.H., Falck J.R., Roman R.J., VanRollins M., Harder D.R. Mechanism of action of cerebral epoxyeicosatrienoic acids on cerebral arterial smooth muscle. Am J Physiol 1992, 263:H519-H525.
21. Gross G.J., Gauthier K.M., Moore J., Campbell W.B., Falck J.R., Nithipatikom K. Evidence for role of epoxyeicosatrienoic acids in mediating ischemic preconditioning and postconditioning in dog. Am J Physiol Heart Circ Physiol 2009, 297:H47-H52.
22. Gross G.J., Gauthier K.M., Moore J., Falck J.R., Hammock B.D., Campbell W.B., Nithipatikom K. Effects of the selective EET antagonist, 14,15-EEZE, on cardioprotection produced by exogenous or endogenous EETs in the canine heart. Am J Physiol Heart Circ Physiol 2008, 294:H2838-H2844.
23. Iliff J.J., Jia J., Nelson J., Goyagi T., Klaus J., Alkayed N.J. Epoxyeicosanoid signaling in CNS function and disease. Prostaglandins Other Lipid Mediat 2010, 91:68-84.
24. Iliff J.J., Wang R., Zeldin D.C., Alkayed N.J. Epoxyeicosanoids as mediators of neurogenic vasodilation in cerebral vessels. Am J Physiol Heart Circ Physiol 2009, 296:H1352-H1363.
25. Jack C.R., Petersen R.C., Xu Y.C., Waring S.C., O'Brien P.C., Tangalos E.G., Smith G.E., Ivnik R.J., Kokmen E. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology 1997, 49:786-794.
26. Karara A., Dishman E., Blair I., Falck J.R., Capdevila J.H. Endogenous epoxyeicosatrienoic acids. Cytochrome P-450 controlled stereoselectivity of the hepatic arachidonic acid epoxygenase. J Biol Chem 1989, 264:19822-19827.
27. Kim H.J., Chae S.C., Lee D.K., Chromy B., Lee S.C., Park Y.C., Klein W.L., Krafft G.A., Hong S.T. Selective neuronal degeneration induced by soluble oligomeric amyloid beta protein. FASEB J 2003, 17:118-120.
28. Kuperstein F., Yavin E. ERK activation and nuclear translocation in amyloid-beta peptide- and iron-stressed neuronal cell cultures. Eur J Neurosci 2002, 16:44-54.
29. Li Y.T., Woodruff-Pak D.S., Trojanowski J.Q. Amyloid plaques in cerebellar cortex and the integrity of Purkinje cell dendrites. Neurobiol Aging 1994, 15:1-9.
30. Liu M., Alkayed N.J. Hypoxic preconditioning and tolerance via hypoxia inducible factor (HIF) 1alpha-linked induction of P450 2C11 epoxygenase in astrocytes. J Cereb Blood Flow Metab 2005, 25:939-948.
31. Liu M., Sun A., Shin E.J., Liu X., Kim S.G., Runyons C.R., Markesbery W., Kim H.C., Bing G. Expression of microsomal epoxide hydrolase is elevated in Alzheimer's hippocampus and induced by exogenous beta-amyloid and trimethyl-tin. Eur J Neurosci 2006, 23:2027-2034.
32. Lue L.F., Kuo Y.M., Roher A.E., Brachova L., Shen Y., Sue L., Beach T., Kurth J.H., Rydel R.E., Rogers J. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am J Pathol 1999, 155:853-862.
33. Magrane J., Rosen K.M., Smith R.C., Walsh K., Gouras G.K., Querfurth H.W. Intraneuronal beta-amyloid expression downregulates the Akt survival pathway and blunts the stress response. J Neurosci 2005, 25:10960-10969.
34. Markesbery W.R., Carney J.M. Oxidative alterations in Alzheimer's disease. Brain Pathol 1999, 9:133-146.
35. McLean C.A., Cherny R.A., Fraser F.W., Fuller S.J., Smith M.J., Beyreuther K., Bush A.I., Masters C.L. Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann Neurol 1999, 46:860-866.
36. Medhora M., Daniels J., Mundey K., Fisslthaler B., Busse R., Jacobs E.R., Harder D.R. Epoxygenase-driven angiogenesis in human lung microvascular endothelial cells. Am J Physiol Heart Circ Physiol 2003, 284:H215-H224.
37. Michaelis U.R., Fisslthaler B., Barbosa-Sicard E., Falck J.R., Fleming I., Busse R. Cytochrome P450 epoxygenases 2C8 and 2C9 are implicated in hypoxia-induced endothelial cell migration and angiogenesis. J Cell Sci 2005, 118:5489-5498.
38. Mullan M., Crawford F. The molecular genetics of Alzheimer's disease. Mol Neurobiol 1994, 9:15-22.
39. Munzenmaier D.H., Harder D.R. Cerebral microvascular endothelial cell tube formation: role of astrocytic epoxyeicosatrienoic acid release. Am J Physiol Heart Circ Physiol 2000, 278:H1163-H1167.
40. Nithipatikom K., Moore J.M., Isbell M.A., Falck J.R., Gross G.J. Epoxyeicosatrienoic acids in cardioprotection: ischemic versus reperfusion injury. Am J Physiol Heart Circ Physiol 2006, 291:H537-H542.
41. Niwa K., Porter V.A., Kazama K., Cornfield D., Carlson G.A., Iadecola C. A beta-peptides enhance vasoconstriction in cerebral circulation. Am J Physiol Heart Circ Physiol 2001, 281:H2417-H2424.
42. Nunez J. Primary culture of hippocampal neurons from P0 newborn rats. J Vis Exp 2008, (19). pii: 895.
43. Paradis E., Douillard H., Koutroumanis M., Goodyer C., LeBlanc A. Amyloid beta peptide of Alzheimer's disease downregulates Bcl-2 and upregulates bax expression in human neurons. J Neurosci 1996, 16:7533-7539.
44. Park L., Anrather J., Forster C., Kazama K., Carlson G.A., Iadecola C. Abeta-induced vascular oxidative stress and attenuation of functional hyperemia in mouse somatosensory cortex. J Cereb Blood Flow Metab 2004, 24:334-342.
45. Park L., Zhou P., Pitstick R., Capone C., Anrather J., Norris E.H., Younkin L., Younkin S., Carlson G., McEwen B.S., Iadecola C. Nox2-derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor protein. Proc Natl Acad Sci U S A 2008, 105:1347-1352.
46. Peng X., Carhuapoma J.R., Bhardwaj A., Alkayed N.J., Falck J.R., Harder D.R., Traystman R.J., Koehler R.C. Suppression of cortical functional hyperemia to vibrissal stimulation in the rat by epoxygenase inhibitors. Am J Physiol Heart Circ Physiol 2002, 283:H2029-H2037.
47. Pike C.J., Burdick D., Walencewicz A.J., Glabe C.G., Cotman C.W. Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state. J Neurosci 1993, 13:1676-1687.
48. Renic M., Klaus J.A., Omura T., Kawashima N., Onishi M., Miyata N., Koehler R.C., Harder D.R., Roman R.J. Effect of 20-HETE inhibition on infarct volume and cerebral blood flow after transient middle cerebral artery occlusion. J Cereb Blood Flow Metab 2009, 29:629-639.
49. Rössler M., Zarski R., Bohl J., Ohm T.G. Stage-dependent and sector-specific neuronal loss in hippocampus during Alzheimer's disease. Acta Neuropathol 2002, 103:363-369.
50. Sanchez-Mejia R.O., Newman J.W., Toh S., Yu G.Q., Zhou Y., Halabisky B., Cisse M., Scearce-Levie K., Cheng I.H., Gan L., Palop J.J., Bonventre J.V., Mucke L. Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease. Nat Neurosci 2008, 11:1311-1318.
51. Selkoe D.J., Schenk D. Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics. Annu Rev Pharmacol Toxicol 2003, 43:545-584.
52. Serrano F., Chang A., Hernandez C., Pautler R.G., Sweatt J.D., Klann E. NADPH oxidase mediates beta-amyloid peptide-induced activation of ERK in hippocampal organotypic cultures. Mol Brain 2009, 5:2-31.
53. Seubert J.M., Sinal C.J., Graves J., DeGraff L.M., Bradbury J.A., Lee C.R., Goralski K., Carey M.A., Luria A., Newman J.W., Hammock B.D., Falck J.R., Roberts H., Rockman H.A., Murphy E., Zeldin D.C. Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function. Circ Res 2006, 99:442-450.
54. Simpkins A.N., Rudic R.D., Schreihofer D.A., Roy S., Manhiani M., Tsai H.J., Hammock B.D., Imig J.D. Soluble epoxide inhibition is protective against cerebral ischemia via vascular and neural protection. Am J Pathol 2009, 174:2086-2095.
55. Stein E.L., Chetkovich D.M. Regulation of stargazin synaptic trafficking by C-terminal PDZ ligand phosphorylation in bidirectional synaptic plasticity. J Neurochem 2010, 113:42-53.
56. Stine W.B., Dahlgren K.N., Krafft G.A., LaDu M.J. In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis. J Biol Chem 2003, 278:11612-11622.
57. Whitwell J.L., Przybelski S.A., Weigand S.D., Knopman D.S., Boeve B.F., Petersen R.C., Jack C.R. 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease. Brain 2007, 130:1777-1786.
58. Wu S., Chen W., Murphy E., Gabel S., Tomer K.B., Foley J., Steenbergen C., Falck J.R., Moomaw C.R., Zeldin D.C. Molecular cloning, expression, and functional significance of a cytochrome P450 highly expressed in rat heart myocytes. J Biol Chem 1997, 272:12551-12559.
59. Wyss-Coray T., Mucke L. Inflammation in neurodegenerative disease-a double-edged sword. Neuron 2002, 35:419-432.
60. Young K.F., Pasternak S.H., Rylett R.J. Oligomeric aggregates of amyloid beta peptide 1-42 activate ERK/MAPK in SH-SY5Y cells via the alpha7 nicotinic receptor. Neurochem Int 2009, 55:796-801.
61. Zagorac D., Jakovcevic D., Gebremedhin D., Harder D.R. Antiangiogenic effect of inhibitors of cytochrome P450 on rats with glioblastoma multiforme. J Cereb Blood Flow Metab 2008, 28:1431-1439.
62. Zeldin D.C. Epoxygenase pathways of arachidonic acid metabolism. J Biol Chem 2001, 276:36059-36062.
63. Zhang C., Harder D.R. Cerebral capillary endothelial cell mitogenesis and morphogenesis induced by astrocytic epoxyeicosatrienoic acid. Stroke 2002, 33:2957-2964.
64. Zhang W., Otsuka T., Sugo N., Ardeshiri A., Alhadid Y.K., Iliff J.J., DeBarber A.E., Koop D.R., Alkayed N.J. Soluble epoxide hydrolase gene deletion is protective against experimental cerebral ischemia. Stroke 2008, 39:2073-2078.
65. Zheng C., Wang L., Li R., Ma B., Tu L., Xu X., Dackor R.T., Zeldin D.C., Wang D.W. Gene delivery of cytochrome p450 epoxygenase ameliorates monocrotaline-induced pulmonary artery hypertension in rats. Am J Respir Cell Mol Biol 2010, 43:740-749.